Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats

被引:11
作者
Liu, XD [1 ]
Zhang [1 ]
Xie, L [1 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China
关键词
nimodipine; P-glycoprotein; blood-brain barrier; cyclosporin A; erythromycin;
D O I
10.1007/BF03220184
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effect of P-glycoprotein (P-gp) inhibitors erythromycin (Ery) and cyclosporin A(CsA) on brain pharmacokinetics of nimodipine (NMD) in rats was studied. NMD concentrations in rat plasma and brain were determined after iv 2 mg/kg NMD alone, coadministration with Ery and CsA, respectively. It was found that concentrations of NMD in plasma of the three groups had a little difference, but brain concentrations of NMD in rats co-administrated with Ery and CsA were significantly higher than those in rats NMD alone. Significances of NMD in rat brain were found at 20,40,60 and 90 min after iv NMD. The brain T-1/2 in rat treated with ery(75.0 min) and CsA(79.0 min) were larger than that(44.2 min) in rats NMD alone. The results indicated that P-gp inhibitors Ery and CsA may increase concentration in rat brain by inhibiting elimination of NMD from brain.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 12 条
[1]  
CHIKHALE EG, 1995, J PHARMACOL EXP THER, V273, P298
[2]   Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats [J].
Hughes, CS ;
Vaden, SL ;
Manaugh, CA ;
Price, GS ;
Hudson, LC .
JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (01) :45-54
[3]  
Liu X. D., 1996, CHIN J PHARM TOXICOL, V10, P25
[4]  
Liu XD, 2002, ACTA PHARMACOL SIN, V23, P225
[5]  
Liu XD, 2001, ACTA PHARMACOL SIN, V22, P111
[6]   Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice [J].
Marques-Santos, LF ;
Bernardo, RR ;
de Paula, EF ;
Rumjanek, VM .
PHARMACOLOGY & TOXICOLOGY, 1999, 84 (03) :125-129
[7]   The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain [J].
Schumacher, U ;
Mollgard, K .
HISTOCHEMISTRY AND CELL BIOLOGY, 1997, 108 (02) :179-182
[8]  
TATSUTA T, 1992, J BIOL CHEM, V267, P20383
[9]   RESTRICTED TRANSPORT OF CYCLOSPORINE-A ACROSS THE BLOOD-BRAIN-BARRIER BY A MULTIDRUG TRANSPORTER, P-GLYCOPROTEIN [J].
TSUJI, A ;
TAMAI, I ;
SAKATA, A ;
TENDA, Y ;
TERASAKI, T .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (06) :1096-1099
[10]   Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo [J].
Wang, L ;
Kitaichi, K ;
Hui, CS ;
Takagi, K ;
Takagi, K ;
Sakai, M ;
Yokogawa, K ;
Miyamoto, K ;
Hasegawa, T .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (08) :587-593